Amyloidosis: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• TTR 56
• BCMA 11
• APOE 0
• SGLT2 0
• CD19 4
• MAPT 0
• CD38 0
• TNF 0
• APP 0
• BCL-2 0
• RET 0
• SNCA 0
• TREM2 0
• GPRC5D 2
• IL-1 0
• IL-6 0
• JAK 0
• LAG-3 0
• PPAR 0
• BACE1 0
• CFTR 0
• CXCR4 0
• EGFR 0
• HIF-1 0
• NRF2 0
• PARP 0
• PI3K 0
• TLR4 0
• TP53 0

4 of 4+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NHLBI · K23

  TARGET-TTR: Targeted Artificial Intelligence-Driven Screening of Transthyretin Amyloid Cardiomyopathy in the Electronic Health Record

  Yale University· New Haven, United States· US$170,964 awarded in fiscal year 2026· until Jul 2031

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Curation, Integration, Modelling and Rational Design of Small Molecule Amyloid Inhibitors (AmyStoppers)

  Vilniaus Universitetas· Vilnius, Lithuania· EU contribution €196,976· until Mar 2029

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Unravelling the Role of Cerebral Amyloid-beta Angiopathy in Epilepsy: Inflammatory Pathways and Interneuron Dysfunction (EPICAA)

  Ludwig-Maximilians-Universitaet Muenchen· Planegg, Germany· EU contribution €217,965· until Feb 2029

• European Commission (Horizon Europe) · HORIZON-ERC

  The Mechanisms of neuronal silencing in Alzheimer’s Disease – investigation of cellular and network mechanisms in mouse models of β-amyloidosis (MONSil-AD)

  Klinikum Der Technischen Universität München (Tum Klinikum)· Muenchen, Germany· EU contribution €1,482,666· until Dec 2030

• European Commission (Horizon 2020) · ERC-COG

  A unified drug discovery platform for protein misfolding diseases (ProMiDis)

  Erevnitiko Kentro Vioiatrikon Epistimon Alexandros Flemingk· Vari-Athens, Greece· EU contribution €1,972,000· until Feb 2027

5 of 5 running projects, newest first. Listed amounts together: US$171.0k + €3.9m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 1
• Mendelian Randomization Analysis 1
• CRISPR-Cas Systems 3
• Gene Expression Profiling 3
• Sequence Analysis, RNA 3
• Exome Sequencing 3
• Proteomics 20
• Metabolomics 2
• Mass Spectrometry 14
• Flow Cytometry 1
• Immunohistochemistry 14
• Positron-Emission Tomography 33
• Magnetic Resonance Imaging 95
• Machine Learning 13
• Deep Learning 4
• Cohort Studies 42
• Genome-Wide Association Study 2

• Cerebral Amyloid Angiopathy in Alzheimer Disease Continuum: Prevalence and Clinical Relevance in a Biomarker-Defined Memory Clinic Cohort.

  Neurology, Nov 2026

• Circulating microRNAs reflect hemorrhagic MRI markers in cerebral amyloid angiopathy.

  Exp Neurol, Oct 2026

• Clinical manifestations and cardiac abnormalities in systemic Amyloid A Amyloidosis.

  Int J Cardiol, Oct 2026

• Comparison of scoring systems in the identification of transthyretin cardiac amyloidosis in a HFpEF cohort.

  Int J Cardiol, Oct 2026

• Machine Learning-Driven Risk Prediction Model in Transthyretin Amyloid Cardiomyopathy.

  JAMA Cardiol, Oct 2026

• Prevalence and determinants of asymmetric septal hypertrophy (ASH) in diseases of left ventricular hypertrophy (LVH).

  Eur Heart J Cardiovasc Imaging, Sept 2026

• Neuropathology of centenarians and supercentenarians: An autopsy study.

  Neurobiol Aging, Sept 2026

• Early vs Delayed Steroid Treatment in Cerebral Amyloid Angiopathy-Related Inflammation: A Retrospective Cohort Study.

  Neurol Neuroimmunol Neuroinflamm, Sept 2026

• LVH-Voltage Discordance and Myocardial Dysfunction in Wild-Type Transthyretin Cardiomyopathy: A Prospective Cohort Study.

  Echocardiography, Sept 2026

• Neuropathological and vascular determinants of cerebral amyloid angiopathy risk: evidence from the NACC cohort.

  Alzheimers Res Ther, Aug 2026

See which targets of this disease your abstract mentions, and go to the people working on them.